VistaGen Therapeutics Q1 EPS $(0.47) Beats $(0.50) Estimate, Sales $244.00K Miss $650.00K Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsEarnings MissesNews
VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.50) by 6 percent. This is a 34.29 percent decrease over losses of $(0.35) per share from
VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.50) by 6 percent. This is a 34.29 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $244.00 thousand which missed the analyst consensus estimate of $650.00 thousand by 62.46 percent. This is a 190.48 percent increase over sales of $84.00 thousand the same period last year.